Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet
This triple-combination tablet, containing Voglibose 0.2mg, Metformin Hydrochloride 500mg, and Gliclazide 80mg, is an antidiabetic medication for adult patients with type 2 diabetes. It's designed to manage blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication is only one component of a comprehensive diabetes management plan, which must include dietary changes, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Maintain regular mealtimes and always carry a readily available glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, and fractures. Weight gain may also occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet
Managing type 2 diabetes
Major Benefits of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet with food.
Common Side effects of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg tablets with meals.
How Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet works:
Voglibose, metformin hydrochloride, and gliclazide (0.2mg/500mg/80mg) tablets, marketed as Genericart, offer a triple-drug approach to diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Voglibose, metformin hydrochloride, and gliclazide (Genericart 0.2mg/500mg/80mg) tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCAUTION
The combination medication Voglibose, Metformin Hydrochloride, and Gliclazide (0.2mg/500mg/80mg) necessitates careful consideration during lactation. Mothers should discontinue breastfeeding until their treatment concludes and the medication is fully cleared from their system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Voglibose/Metformin Hydrochloride/Gliclazide (0.2mg/500mg/80mg) tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Voglibose, metformin hydrochloride, and gliclazide (0.2mg/500mg/80mg) should be administered cautiously to individuals with hepatic impairment. Dosage modification may be necessary. Medical advice is recommended. Treatment with this combination (0.2mg/500mg/80mg) typically begins with a reduced dose for those with mild to moderate liver disease; it's contraindicated in cases of severe liver dysfunction.
What if you forget to take Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet :
NA
Facts to Know About Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/80mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently